Daratumumab and dexamethasone is safe and effective for triple refractory myeloma patients: final results of the IFM 2014-04 (Etoile du Nord) trial
Boyle, Eileen M., Leleu, Xavier, Petillon, Marie-Odile, Karlin, Lionel, Doyen, Chantal, Demarquette, Hélène, Royer, Bruno, Macro, Margaret, Moreau, Philippe, Fostier, Karel, Marie-Lorraine, Chretien,Журнал:
British Journal of Haematology
DOI:
10.1111/bjh.16059
Date:
June, 2019
Файл:
PDF, 236 KB
2019
File converter
Більше результатів пошуку
More benefits 
